API & INTERMEDIATES
Active Pharmaceuticals Ingredients (APIs)
Therapeutic Area Products Status
Anti-Cancer Irinotecan Hydrochloride USDMF No. 30516 / CEP (Pipeline)/ WHO GMP
Anti-Cancer Lenalidomide Open part DMF/ WHO GMP
Anti-Thrombotic Ticagrelor Open Part DMF / WHO GMP
Anti-Ulcer Misoprostol 1% dispersion in HPMC Tech Pack
Anti-Cancer Pazopanib Hydrochloride COA and samples (ODMF-Pipeline)
Anti-Cancer Carfilzomib COA and samples
Anti-Cancer Methotrexate COA and samples (ODMF-Pipeline)
Anti-Cancer Topotecan Hydrochloride COA
Anti-Cancer Palbociclib R&D
Hematology Eltrombopag Olamine COA and samples (ODMF-Pipeline)
PAH Macitentan R&D
Psoriatic Arthritis Apremilast R&D
Antipsychotic Pimavanserin R&D
Intermediates
Name CAS No.
Irinotecan Intermediates
7-Ethyl-10-hydroxycamptothecin (SN-38) (USDMF No. 27429) 86639-52-3
(S)-8-Ethyl-8-hydroxy-2,3,5,8-tetrahydro-6-oxa-3a-aza-cyclopenta [b]naphthalene-1,4,7-trione 110351-94-5
2’-Amino-5’-hydroxypropiophenone 35364-15-9
Topotecan Intermediate
10-Hydroxycamptothecin (USDMF No. 26025) 19685-09-07
Pazopanib HCl Intermediate
2,4-Dichloropyrimidine 3934-20-1
5-Amino-2-methylbenzenesulfonamide 6973-09-7
Ticagrelor Intermediate
2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d](1,3)dioxol-4-yl)oxy)ethanol, 274693-26-4
Carfilzomib Intermediates
(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid 868540-16-3
(S)-2-amino-4-methyl-1-((R)-2-methyloxiran-2-yl)pentan-1-one trifluoroacetic acid salt 247068-85-5
Osimertinib Intermediates
4-Fluoro-2-methoxy-5-nitroaniline 1075705-01-9
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine 1421372-94-2
Dapagliflozin and Ertugliflozin Intermediates
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone 461432-22-4
5-Bromo-2-chloro-4'-ethoxydiphenylmethane 461432-23-5
Eltrombopag olamine
3'-amino-2'-hydroxy-1,1'-biphenyl-3-carboxylic acid 376592-93-7
Others
Camptothecin 7689-03-4
7-Ethylcamptothecin 78287-27-1
Olivetol 500-66-3
Ethyl olivetolate 38862-65-6
3-Oxocyclobutanecarboxylic acid 23761-23-1
6-Hydroxy-1,2,3,4-tetrahydroisoquinoline 14446-24-3
2-Amino-5-bromobenzaldehyde 29124-57-0
2,6-Dimethylmorpholine 141-91-3
2,4-Dimethoxypyrimidine 3551-55-1
Quinoxaline-2-carboxaldehyde 1593-08-4
2-Chloro-1,3,2-dioxaphospholane 2-oxide 6609-64-9
3,4-benzyloxybenzaldehyde 1700-37-4
2-Ethylmorpholine 52769-10-5
4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 286961-14-6
trans-1-Propenylboronic acid pinacol ester 83947-58-4
Trimethylsulfoxonium chloride 5034-06-0
Tri-tert-butylphosphoniumtetrafluoroborate 131274-22-1
2-phenylpyridine 1008-89-5
3-Hydroxyazetidine hydrochloride 18621-18-6
3-Bromopyridazine Hydrobromide ----
All transactions are carried out in conformity with patent laws applicable in the user country. Responsibility with respect to third party's patent right in a specific country lies exclusively with the buyer. Products currently covered by valid US patents are offered for R&D use in accordance with 35 USC 271 A13(1)